Gemcitabine-(C4-amide)-[anti-HER2/neu] Anti-Neoplastic Cytotoxicity in Dual Combination with Mebendazole against Chemotherapeutic-Resistant Mammary Adenocarcinoma.
about
Gemcitabine-(5'-phosphoramidate)-[anti-IGF-1R]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency in populations of pulmonary adenocarcinoma (A549)Repurposing Drugs in Oncology (ReDO)-mebendazole as an anti-cancer agentAnti-Neoplastic Cytotoxicity of Gemcitabine-(C4-amide)-[anti-EGFR] in Dual-combination with Epirubicin-(C3-amide)-[anti-HER2/neu] against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3) and the Complementary Effect of Mebendazole.Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC).Personalized Drug Analysis in B Cell Chronic Lymphocytic Leukemia Patients.
P2860
Gemcitabine-(C4-amide)-[anti-HER2/neu] Anti-Neoplastic Cytotoxicity in Dual Combination with Mebendazole against Chemotherapeutic-Resistant Mammary Adenocarcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Gemcitabine-(C4-amide)-[anti-H ...... istant Mammary Adenocarcinoma.
@en
type
label
Gemcitabine-(C4-amide)-[anti-H ...... istant Mammary Adenocarcinoma.
@en
prefLabel
Gemcitabine-(C4-amide)-[anti-H ...... istant Mammary Adenocarcinoma.
@en
P2093
P2860
P1476
Gemcitabine-(C4-amide)-[anti-H ...... sistant Mammary Adenocarcinoma
@en
P2093
P2860
P577
2013-01-01T00:00:00Z